AVAMYS

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug AVAMYS contains one active pharmaceutical ingredient (API):

1 Fluticasone furoate UNII JS86977WNV - FLUTICASONE FUROATE

Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action. Read about Fluticasone furoate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AVAMYS Nasal spray, suspension	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AD12	Fluticasone furoate	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510611301139217
Country: CA	Health Products and Food Branch	Identifier(s): 02298589
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01329937, 02425979, 13696167
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28526-08-08, 7375-MEE-0722
Country: EE	Ravimiamet	Identifier(s): 1343012, 1343023, 1343034
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 07434003, 07434003IP, 07434003IP1, 07434003IP4
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 088261
Country: FR	Base de données publique des médicaments	Identifier(s): 66921927
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 150464, 180514, 381185
Country: HK	Department of Health Drug Office	Identifier(s): 56691
Country: IE	Health Products Regulatory Authority	Identifier(s): 53605, 53612, 53625, 53632, 53645
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6400
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005666, 1032059, 1032060
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 214M2009
Country: NL	Z-Index G-Standaard	Identifier(s): 14236664
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 85847
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100181056
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65298001, W65298002, W65298003
Country: SG	Health Sciences Authority	Identifier(s): 13666P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 24833011, 2883011
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522541379
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/21.5.1/0968